© 2024 Michigan State University Board of Trustees
Public Media from Michigan State University
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Why FDA approval of sickle cell gene therapy is a ‘big deal’

Season 2023 Episode 354 | 5m 08s

Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor Dr. Cece Calhoun and New York Times reporter Gina Kolata to learn more.

Major corporate funding for the PBS NewsHour is provided by BDO, BNSF, Consumer Cellular, Cunard Cruise Lines, and Raymond James. Funding for the PBS NewsHour Weekend is provided by Consumer Cellular and Cunard Cruise Lines. For a complete list of funders for the PBS NewsHour and PBS NewsHour weekend, click here.
Extras
LeBron James, Caitlin Clark break all-time records in NBA and NCAA basketball
March 3, 2024 - PBS News Weekend full episode
Why more people are turning to artificial intelligence for companionship
Mexico City is running out of water. Here’s why and how millions of residents are affected
News Wrap: Haley rebuffs RNC pledge to back Republican presidential nominee
March 2, 2024 - PBS News Weekend full episode
News Wrap: U.S. airdrops aid into Gaza as cease-fire proposal moves a step forward
Why support for crisis pregnancy centers is surging after the end of Roe v. Wade
Can these scientific breakthroughs save the northern white rhino from extinction?
A Brief But Spectacular take on the importance of bereavement care